Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol — United States, May–August 2022

por O’Laughlin, Kevin, Tobolowsky, Farrell A., Elmor, Riad, Overton, Rahsaan, O’Connor, Siobhán M., Damon, Inger K., Petersen, Brett W., Rao, Agam K., Chatham-Stephens, Kevin, Yu, Patricia, Yu, Yon, Ahmadi, Sarah, Avery, Rachel, Bean, Kathryn, Beavers, Leah, Belanger Giguere, Kim, Brownlee, Joi, Campbell, Catherine, Cheng, Maggie, Clinton, Rachel, Coleman, Taylor, Davis, Monique S., Dubreus, Marie, Henry, Meryl, Lozoya, Sujeith B., Morgan, Jahnae, Muhammad, Kalimah, Parker, Corinne M., Peters, Nigel, Rybak, Ellery, Schwenk, Andrew, van Loben Sels, Jessica, Veillard,, Max
Publicado 2022